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Abstract
Terminalia chebula (family: Combretaceae) is wide-
ly used in the traditional medicine of India and Iran
to treat diseases that include dementia, constipa-
tion, and diabetes. This tree is known in Iranian tra-
ditional medicine (ITM) as halileh or halilaj and the
fruit is used to develop treatments. It is described
in ITM as an astringent that has a "cold" and "dry"
temperament. References to the medicinal proper-
ties of Terminalia chebula were collected from im-
portant ITM sources and from modern medical da-
tabases (PubMed, Scirus, ScienceDirect, and Sco-
pus). The medicinal properties described for this
tree in ITM were compared with those reported in
studies of modern phytotherapy. The results con-
firm that the tree referred to as halileh in traditional
books is the Terminalia chebula used in pres-
ent-day studies. Treatments that have not been
evaluated in modern phytotherapy but have been
traditionally treated with Terminalia chebula in-
clude fever, and psychological and psychiatric is-
sues. This article confirms the medicinal uses of Ter-
minalia chebula.
© 2016 JTCM. All rights reserved.
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INTRODUCTION
Terminalia chebula (myrobalan) is a commonly con-
sumed herb used in Indian traditional medicine that
has been adopted for use in Iranian traditional medi-
cine (ITM). Traditional Iranian physicians have used
the herb to treat many diseases. Myrobalan is referred
to as halileh in ITM textbooks in Farsi, ah-halilaj in Ar-
abic, and harharu in Hindi.1,2
Myrobalan has a well-documented history of use in tra-
ditional medicines to treat disease. ITM bases the use
of medications on the temperament of the substance.
These temperaments cannot be defined using laborato-
ry criteria, so myrobalan was assessed according to
modern scientific standards to allow comparison of tra-
ditional and modern scientific findings.
In both ITM and modern phytotherapy, the main me-
dicinal part of myrobalan is the fruit. The pharmaco-
logically active compounds of myrobalan are total phe-
nols (tannins). ITM states that all things are composed
of four elements and the differences between objects
can be attributed to the ratios of these four elements in
each object. Thus, every object has a specific quality
250
JTCM |www. journaltcm. com April 15, 2016 |Volume 36 | Issue 21 |
Jokar A et al. / Review
based on its dominant element (s). This specific quality
is known as temperament (midzaj).3-5 Belief in the tem-
perament of objects is common to many types of tradi-
tional medicine, including Greek, Arabic, Roman, Indi-
an, European, and Traditional Chinese Medicine.6
Plants are also thought to be composed of the four ele-
ments and adhere to specific rules.
Myrobalan is believed to have a cold and dry nature in
ITM. The present study reviewed and compared the
pharmacological uses of myrobalan in ITM and mod-
ern phytotherapy. ITM and modern phytotherapy rec-
ommendations about the safety and acceptable dosages
for the medicines made from this plant are discussed.
METHODS ANDMATERIALS
Major ancient sources of information about ITM were
consulted. The following sources were searched for in-
formation about halileh for the treatment of disease:
the Avicenna's Canon, Al-Igraz, At-Tibbieh, Al-Maba-
his, Al-Alaieh, Axirazam, Sharhe-Asbab, Akbari medi-
cine, and Kholasat-Al-Hekmaa. The habitat, appear-
ance, and properties of this herb as described in ITM
were recorded.
The following modern botanical sources and databases
were searched for the key words "Terminalia chebula"
and myrobalan: ScienceDirect, Google Scholar, Iranme-
dex, PubMed, Scirus, and Scopus. These key words
were combined with the terms "phytochemistry" and
"pharmacology" to search for phytochemical and phar-
macological properties of myrobalan. The articles were
selected based on academic and scientific journal. The
results were compared with the findings from ITM
sources. This method of data collection was used to
control for possible publication bias.
RESULTS
Shape and structure
Terminalia chebula is a traditional plant belonging to
the genus Terminalia, family Combretaceae. It is native
to India and Southeast Asia and is commonly known
as myrobalan in English.7-9 It is extensively cultivated in
Taiwan and India.8,10 The fruit of the tree is the most
important part. If unripe fruit is picked from the tree
and dried, it becomes black in color and is then called
black myrobalan. The fruit is yellow when it is fully
ripe. When the yellow fruit has dried, it becomes very
hard and is known as yellow myrobalan. The tannin
content of the fruit increases as it ripens.9 The best my-
robalan fruit for use in ITM is stiff, heavy, free from de-
cay, and sinks in water.4,11
ITM and myrobalan
ITM physicians believe that the fruit of the myrobalan
tree has a water component that is called an extract
and an earth component that is called scum. Addition-
ally, it contains moisture (rotoobat fazliyye) that is res-
inous. The earthy components comprise two parts:
cool components, and burnt and hot components.
Cool components are acrid and astringent. Burnt and
hot components are bitter and tender. Moisture can
contain air components that make the fruit oily in ap-
pearance. The interaction of these basic components
forms the temperament of myrobalan, which is cold
and dry.11
Phytochemistry of myrobalan
Steroids/sapogenins, saponins, anthraquinone deriva-
tives, flavonoids, and tannins were detected in the fruit
of myrobalan.8 The most important component in the
fruit is tannin. Terminalia chebula has a tannin content
of 32%-45% that includes gallic acid, ellagic acid, che-
bulic acid, chebulinic acid, punicalagin, and tannic ac-
id. The flavonoids quercetin, catechin, and kaempferol
have been detected. Monosaccharides/oligosaccharides
(9%) detected are D-glucose, D-fructose, and saccha-
rose. The fruit acids include quinic acid (1.5% ), shi-
kimic acid (2%), and fatty oil (from seeds; 40%). The
high tannin content of myrobalan makes it popular for
use as an astringent.8,12,13
Psychological and psychiatric uses
ITM sources report that myrobalan strengthens memo-
ry retention and brain activity. It is reported useful for
confusion, headache, melancholy, depression, obses-
sion, amnesia, facial paralysis, misanthropy, dizziness,
and insomnia. Traditional texts report that it helps to
prevent stomach vapors from ascending into the brain
and evacuates phlegmatic excreta from the brain.1,3,4
Ophthalmic effects
Myrobalan aids visual acuity and drainage from the
eyes;4 it is an eye tonic, a desiccant of moisture in the
eye, and is useful for epiphoria and eye irritation when
soaked in rosewater.11,14
Cardiopulmonary effects
Myrobalan refreshes the heart and is useful in treating
palpitations and tachycardia.11
Gastrointestinal effects
A myrobalan tonic for the stomach controls vomiting
and diarrhea (roasted), absorbs stomach moisture, and
increases stomach retention and appetite. It is a diges-
tive, laxative (soaked), and decreases hemorrhoidal
bleeding (burnt powder).1-4,11,14
Hepatic, splenic, and urinary effects
A liver tonic (jam) of myrobalan moderates liver tem-
perament and is used to treat generalized dropsy and
spleen pain, as a diuretic, and for treatment of poly-
pus.1,3,11
Dermatologic effects
Myrobalan improves paleness, decreases greying of the
hair, and is a hair tonic (when sucked). It is also effec-
tive in the treatment of leprosy.1-3,11,14
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Dental and oral cavity effects
Myrobalan strengthens the gums and teeth and is bene-
ficial in treating mouth ulcers, aphthous, and milk fe-
ver.1-3,11,14
General effects
General effects of myrobalan include opening of block-
ages, quenching bile heat, and preventing the develop-
ment of burning black bile. It is effective for treating
combined fever, diluting phlegm, and as a bile laxative
(squeezed), to dry humidity (sprinkling powder), as a
phlegm solvent, for joint pain, and for relief of boiling
humors.1-3,11 It is harmful in irritable bowel disease and
irritable bowel syndrome.1,3
Pharmacological effects
Animal experiments show that the fruit has remarkable
effects in decreasing blood sugar levels and improving
diabetes. Research shows a significant antidiabetic and
renoprotective effect from a chloroform extract of my-
robalan, which enhanced insulin secretion from the β-
cells in the islets of Langerhans, or by an extra pancreat-
ic mechanism, which supports its traditional usage.10,15
The cardiotonic activity of myrobalan fruits has been
demonstrated. Myrobalan increases the force of con-
tractions and cardiac outputwithout altering heart rate.16
The benefits of myrobalan for the skin have also been
shown. It is effective for healing wounds and treats
wounds quickly, as indicated by the increased rates of
contraction and decreased periods of epithelialization.
Biochemical studies show a significant increase in total
protein, DNA, and collagen content in the granulation
tissues of treated wounds. In addition, myrobalan has
antimicrobial and antioxidant properties. These results
confirm the beneficial effects of myrobalan on the ac-
celeration of healing.17
Myrobalan has antiulcerative properties on the gastric
mucosa. The gastroprotective and antisecretory mecha-
nisms of chebulinic acid isolated from myrobalan fruit
have been demonstrated. Chebulinic acid significantly
decreases free acidity, total acidity, and upregulated mu-
cin secretion, and inhibits H+K+-ATPase activity. It is
employed to treat gastrointestinal ailments against Heli-
cobacter pylori.18,19
The fruit of myrobalan contains antioxidant agents, in-
cluding quercetin and vitamin C, which work against
oxidative stress-induced neurodegeneration. It can de-
crease the risk of neurodegenerative disorders such as
dementia and Parkinson's disease.11,12,20 As myrobalan
contains a large percentage of tannin, it is beneficial for
decreasing gingival bleeding, aphthous, and other in-
flammatory mouth diseases. It is a potent antimicrobial
against microorganisms that form dental caries.21,22
Myrobalan has antiarthritic properties that can be bene-
ficial for the treatment of rheumatoid arthritis by de-
creasing serum tumor necrosis factor-α levels.23 It offers
antibacterial, antiviral, and antifungal effects. The etha-
nolic extract of myrobalan fruit has been found effec-
tive against both gram-positive and gram-negative bac-
teria such as Salmonella typhi, Staphylococcus epider-
midis, Staphylococcus aureus, Bacillus subtilis, and
Pseudomonas aeruginosa. It is also effective against He-
licobacter pylori. Ellagic acid exerts a potent inhibitory
effect against C. perfringens and E. coli. An aqueous
extract of myrobalan has been reported to show anti-
fungal activity against a number of dermatophytes.24,25
A hot water extract of myrobalan shows antiherpes sim-
plex virus activity, anticytomegalovirus activity, and an-
tiHIV-1 activity.26-29
Hepatoprotective compounds have been isolated from
the extract of myrobalan fruits. Chebulic acid has an
antioxidant effect and exhibits free radical scavenging
activity in vitro and ferric-reducing antioxidant activity.
The treatment of hepatocytes with chebulic acid signifi-
cantly reduces cell cytotoxicity.30 Myrobalan is also reti-
noprotective,31 cytoprotective,18,32 and offers antiaging,32,
33 antinociceptive,34 antianaphylactic,35 and radio protec-
tive25 activities.
Mode of application in ITM
The fruit should not be finely powdered, but should be
partially pounded. The fruit is more effective when
first soaked in water than as a decoction or powder.
Eating the dry fruit can cause colic. ITM uses Myroba-
lan in different forms: dry fruit, decoction, and soaked
fruit. It is more effective when combined with jujube,
almond oil, fresh cow oil, sugar, manna, and honey
(These material are corrector. In ITM, There is an Idi-
om: Corrector that it help to reduce the side effect of
plants for example ancient physician were believed half
crushed Myrobalan sticks in the bowel and fresh cow
oil can prevent.).1,11 The mode of administration is
whole herb preparations for internal and external use.
Daily dosage ranges from 3 to 9 g. A study on acute
toxicity showed that the oral LD50 dose for myrobalan
is >2000 mg/kg. Chronic administration to rats did
not produce significant physiological changes when
compared with control rats.26
DISCUSSION
This study of traditional medicine texts shows that my-
robalan has been an important plant in traditional
medicine. It was shown that halileh in ITM is equiva-
lent to the myrobalan tree with the scientific name Ter-
minalia chebula. Some pharmacological properties doc-
umented for this plant in ITM have been confirmed
by studies of modern phytotherapy.
The morphology of this plant recorded in traditional
texts includes details about habitat and therapeutic ac-
tivity that match those of modern findings. These prop-
erties include the use of the fruit for its gastroprotec-
tive effects and its use for Alzheimer's disease treat-
ment, gingival bleeding, and wound healing.
The therapeutic dosages in modern phytotherapy
range from 3 to 9 g, while therapeutic dosages in ITM
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range from 15 to 30 g. The higher therapeutic dose in
ITM may be because myrobalan fruit is decocted or
soaked, and because ITM is a holistic therapeutic sys-
tem and the nature of the patient is considered before
treatment. Its records show that the most serious ad-
verse effects of myrobalan are observed in people with
a cool temperament; thus, it is not prescribed for such
patients. Modern medicine does not consider the na-
ture of patients before treatment; however, it is recom-
mended to avoid the administration of high doses until
adequate studies confirm their safety and quality. How-
ever, no serious toxicity or adverse effects have been re-
corded after ingestion of myrobalan.
The morphology and habitat indicate that myrobalan
is the plant described in traditional books. Some of the
remedies used may be derived from traditional applica-
tions. The ITM medicinal properties described for this
plant have been demonstrated in modern phytothera-
py. Its abundant tannin content produces high astrin-
gency and it has a cold and dry temperament.29 Its as-
tringent nature makes it an effective tonic for organs
such as the stomach, heart, and liver. Although mod-
ern pharmacological mechanisms are different from the
mechanisms described in traditional documents, the re-
sults of both approaches are similar. 8,26
The results of this study confirm the use of Myrobalan.
As the main sources of study are Iranian medical texts,
researchers and medical experts can use these findings
as a basis for further study. Myrobalan has been used to
treat disease for hundreds of years, so the probability of
bias is very low and the results have been confirmed by
recent research. Physicians can base their treatments on
this confirmation of indications, dosage, toxicity, and
patient and drug temperament.
ITM uses roasted myrobalan fruit in the treatment of
diarrhea because of its high tannin content, and uses
soaked myrobalan fruit as a laxative because of its an-
thraquinone derivative content. This indicates that dif-
ferent forms of the drug can be applied for different or
contradictory effects. Myrobalan is a tonic for the stom-
ach and heart and has a cold temperament. Its tonic ef-
fects in ITM are the result of its cold temperament.
These effects cannot be found in substances with hot
temperaments.
ITM's comprehensive knowledge of the temperament
of substances (plants, animals, and minerals) is helpful
in understanding the function of a substance. Myroba-
lan has extensive therapeutic applications in ITM,
some of which have been confirmed by modern medi-
cine. Future study could focus on previously untested
therapeutic applications of myrobalan.
This review provides a basis for researchers to use ITM
information about Terminalia chebula. It is an effica-
cious natural drug and its safety and acceptable dosage
have been determined. Further preclinical and clinical
studies for adequate evaluation of its safety and thera-
peutic efficacy are recommended.
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